跳至主要内容
临床试验/CTRI/2020/04/024735
CTRI/2020/04/024735尚未招募未知

Clinical significance of soluble programmed death-1 (sPD-1) and soluble programmed death ligand-1 (sPD-L1); and their correlation with membrane bound PD-1 (mPD-1), mPD-L1; interleukins 2, 7, 15; and interferon gamma in patients having vitiligo

Pigmentary Disorders Society India0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Consecutive patients with clinical diagnosis of vitiligo vulgaris; and age > 18 years and <60 years will be recruited in this study.
  • The study shall include 40 consecutive patients having vitiligo (20 stable, 20 active) attending the Pigmentary Clinic of the Department of Dermatology, Venereology and Leprology at Postgraduate Institute of Medical Education and Research, Chandigarh.
  • Controls: Ten healthy individuals (accompanying the patients and having no skin/ systemic disease) will be taken as controls.

排除标准

  • Leucoderma secondary to other causes
  • Pregnancy/Lactation
  • Patients with severe hepatic, renal, thyroid or other systemic disorder
  • Pre-existing malignancy
  • Any other skin disease
  • Patients receiving topical or systemic therapy of any form for vitiligo in past 6 weeks.

研究者

发起方
Pigmentary Disorders Society India

相似试验